AMENDMENT NO. 2 TO THE AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • November 12th, 2010 • Hana Biosciences Inc • Pharmaceutical preparations
This AMENDMENT NO. 2 TO THE AMENDED AND RESTATED LICENSE AGREEMENT (this “Amendment No. 2”) is made effective as of September 20, 2010 (the “Amendment No. 2 Effective Date”) by and between TEKMIRA PHARMACEUTICALS CORPORATION (formerly INEX PHARMACEUTICALS CORPORATION), a company duly incorporated under the laws of British Columbia having an office at #100 – 8900 Glenlyon Parkway, Burnaby, British Columbia, Canada V5J 5J8 (“Tekmira”) and HANA BIOSCIENCES, INC., a company duly incorporated under the laws of Delaware having an office at 7000 Shoreline Court, Suite 370, South San Francisco, CA 94080, U.S.A. (“Hana”) (each of HANA and TEKMIRA a “Party,” and collectively, the “Parties”).
